CLINICAL_TRIALS
trial_result
· 2009-06-05
Clinical Trial Update: Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 [Phase 2]
Summary
A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics and safety of FE200486 in prostate cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-06-05